Merit Medical Systems, Inc. (NASDAQ:MMSI) Director Kent W. Stanger Sells 5,000 Shares

Merit Medical Systems, Inc. (NASDAQ:MMSI) Director Kent W. Stanger sold 5,000 shares of the company’s stock in a transaction that occurred on Thursday, March 28th. The shares were sold at an average price of $60.34, for a total value of $301,700.00. Following the completion of the sale, the director now owns 19,038 shares in the company, valued at $1,148,752.92. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Kent W. Stanger also recently made the following trade(s):

  • On Tuesday, March 26th, Kent W. Stanger sold 1,216 shares of Merit Medical Systems stock. The shares were sold at an average price of $60.54, for a total value of $73,616.64.

NASDAQ:MMSI traded down $0.14 during trading hours on Friday, hitting $57.66. 649,614 shares of the stock were exchanged, compared to its average volume of 344,034. Merit Medical Systems, Inc. has a twelve month low of $44.05 and a twelve month high of $66.34. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.32 and a current ratio of 2.45. The company has a market cap of $3.17 billion, a price-to-earnings ratio of 34.12, a P/E/G ratio of 2.47 and a beta of 1.11.

Merit Medical Systems (NASDAQ:MMSI) last posted its quarterly earnings data on Tuesday, February 26th. The medical instruments supplier reported $0.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.45 by $0.03. Merit Medical Systems had a return on equity of 11.26% and a net margin of 4.76%. The firm had revenue of $232.25 million for the quarter, compared to the consensus estimate of $231.03 million. During the same quarter in the prior year, the business earned $0.33 EPS. The business’s revenue for the quarter was up 21.7% compared to the same quarter last year. On average, equities analysts predict that Merit Medical Systems, Inc. will post 2.01 EPS for the current fiscal year.

Large investors have recently bought and sold shares of the business. BlackRock Inc. raised its position in shares of Merit Medical Systems by 13.3% during the 3rd quarter. BlackRock Inc. now owns 7,985,361 shares of the medical instruments supplier’s stock valued at $490,700,000 after acquiring an additional 939,589 shares during the last quarter. Vanguard Group Inc. increased its position in shares of Merit Medical Systems by 11.0% in the 3rd quarter. Vanguard Group Inc. now owns 5,286,818 shares of the medical instruments supplier’s stock valued at $324,875,000 after buying an additional 522,994 shares in the last quarter. Vanguard Group Inc increased its position in shares of Merit Medical Systems by 11.0% in the 3rd quarter. Vanguard Group Inc now owns 5,286,818 shares of the medical instruments supplier’s stock valued at $324,875,000 after buying an additional 522,994 shares in the last quarter. FMR LLC increased its position in shares of Merit Medical Systems by 175.4% in the 4th quarter. FMR LLC now owns 1,636,479 shares of the medical instruments supplier’s stock valued at $91,332,000 after buying an additional 1,042,364 shares in the last quarter. Finally, Point72 Asset Management L.P. increased its position in shares of Merit Medical Systems by 950.2% in the 3rd quarter. Point72 Asset Management L.P. now owns 1,345,468 shares of the medical instruments supplier’s stock valued at $82,679,000 after buying an additional 1,217,352 shares in the last quarter. 97.79% of the stock is currently owned by hedge funds and other institutional investors.

Several equities research analysts have recently weighed in on the company. Zacks Investment Research lowered Merit Medical Systems from a “buy” rating to a “hold” rating in a research note on Wednesday, March 13th. BidaskClub downgraded Merit Medical Systems from a “buy” rating to a “hold” rating in a report on Wednesday, February 27th. One analyst has rated the stock with a sell rating, two have given a hold rating, eight have issued a buy rating and one has given a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $67.60.

TRADEMARK VIOLATION NOTICE: “Merit Medical Systems, Inc. (NASDAQ:MMSI) Director Kent W. Stanger Sells 5,000 Shares” was first posted by Baseball Daily News and is owned by of Baseball Daily News. If you are reading this piece on another domain, it was copied illegally and reposted in violation of U.S. and international trademark & copyright law. The original version of this piece can be read at https://www.baseballdailydigest.com/news/2019/04/21/kent-w-stanger-sells-5000-shares-of-merit-medical-systems-inc-mmsi-stock.html.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through Cardiovascular and Endoscopy segments. It provides peripheral intervention products, including access, angiography, intervention, and drainage and biopsy for diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, hemostasis, intervention, and electrophysiology and cardiac rhythm management products to treat various heart conditions.

Featured Article: Put Option Volume

Insider Buying and Selling by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.